Demystifying Multiple Sclerosis Etiology: The Role of Epstein-Barr Virus

Alberto Ascherio, MD, DrPH, recaps key findings and learning from a recently published study that he coauthored demonstrating a causal relationship between MS and Epstein-Barr virus.

Avindra Nath, MD, explains the importance of understanding virology when treating autoimmune diseases.

Anne Cross, MD, and Michael Racke, MD, discuss how the immune system is primed in multiple sclerosis.

Alberto Ascherio, MD, DrPH, highlights key risk factors leading to increased prevalence of multiple sclerosis.

A panel of experts probe the variations in immune response to Epstein-Barr virus in patients with multiple sclerosis.

The expert panelists comment on intervention efforts underway to address multiple sclerosis prevention and treatment.

Alberto Ascherio, MD, DrPH; Anne Cross, MD; and Michael Racke, MD, discuss implications for patient communication and other advances from bench to bedside.

Alberto Ascherio, MD, DrPH, addresses the range of latency periods for Epstein-Barr virus and the impact on onset multiple sclerosis.

Expert panelists review the viability of new treatments in development for multiple sclerosis.

Looking to the future of multiple sclerosis care, the panel of thought leaders pose important questions that remain to be answered in the research and treatment of multiple sclerosis.